Table 4.
p-value | Exp(B) | CI 95.0% per exp(B) | ||
---|---|---|---|---|
Lower | Upper | |||
Gender | 0.624 | 1.093 | 0.765 | 1.562 |
Age | 0.064 | 0.984 | 0.966 | 1.001 |
Lag time (between onset and diagnosis) | 0.254 | 0.998 | 0.995 | 1.001 |
Gender | 0.624 | 1.093 | 0.765 | 1.562 |
Smokers | 0.614 | 1.015 | 0.712 | 1.075 |
BMI | 0.627 | 1.015 | 0.954 | 1.080 |
Lag time (between onset and diagnosis) | 0.330 | 1.003 | 0.997 | 1.008 |
Hypertension | 0.374 | 1.566 | 0.583 | 4.210 |
Dyslipidaemia | 0.941 | 1.029 | 0.485 | 2.184 |
Number of relapses within the year before diagnosis | 0.029 | 2.340 | 1.090 | 5.022 |
EDSS at the first DMT beginning | 0.346 | 1.099 | 0.903 | 1.336 |
Number of T2-weighted lesions within the year before diagnosis | 0.327 | 1.059 | 0.839 | 1.336 |
Number of T1 Gad+-weighted lesions within the year before diagnosis | 0.630 | 1.377 | 1.044 | 1.815 |
Treatment line | 0.062 | 1.702 | 0.974 | 2.973 |
BMI, Body Mass Index; CI, confidence interval; DMT, disease-modifying therapy; EDSS, Expanded Disability Status Scale; Gad+, Gadolinium.